University of Michigan Health System, based in Ann Arbor, Mich., will use a $3.5 million federal grant to study a new approach in halting the downward spiral of diabetes.
The National Institute of Diabetes and Digestive and Kidney Diseases will fund the university's work to examine tissue-specific metabolic reprogramming in diabetes complications.
The university's team of researchers specifically proposes that diabetes disrupts basic metabolic pathways in complication-prone tissues and that understanding these altered pathways will provide new targets for drug therapies that could prevent or treat diabetes complications, including diabetes-related blindness, nerve damage and kidney failure.
University of Michigan Health Pushes Back Opening of Women's, Children's Hospitals
U Michigan Nurses, Leadership Battle Over Contract Negotiations
The National Institute of Diabetes and Digestive and Kidney Diseases will fund the university's work to examine tissue-specific metabolic reprogramming in diabetes complications.
The university's team of researchers specifically proposes that diabetes disrupts basic metabolic pathways in complication-prone tissues and that understanding these altered pathways will provide new targets for drug therapies that could prevent or treat diabetes complications, including diabetes-related blindness, nerve damage and kidney failure.
Related Articles on University of Michigan Health System:
University of Michigan Health Partners With Great Lakes Health Information ExchangeUniversity of Michigan Health Pushes Back Opening of Women's, Children's Hospitals
U Michigan Nurses, Leadership Battle Over Contract Negotiations